Next Article in Journal
Comparison of Ground-Based PM2.5 and PM10 Concentrations in China, India, and the U.S.
Previous Article in Journal
In Vitro and In Vivo Experimental Studies of PM2.5 on Disease Progression
Open AccessArticle

Influenza Vaccination in Type 2 Diabetes Patients: Coverage Status and Its Determinants in Southwestern Saudi Arabia

1
Joint Program for Postgraduate Studies in Community Medicine-Southern Region, Abha 61421, Saudi Arabia
2
Department of Family and Community Medicine, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia
3
Department of Community Medicine, Faculty of Medicine, Mansoura University, Mansoura 3551, Egypt
4
Aseer General Directorate of Health Affairs, Ministry of Health, Abha 62523, Saudi Arabia
5
Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria 21511, Egypt
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2018, 15(7), 1381; https://doi.org/10.3390/ijerph15071381
Received: 1 June 2018 / Revised: 27 June 2018 / Accepted: 29 June 2018 / Published: 1 July 2018
(This article belongs to the Section Health Behavior, Chronic Disease and Health Promotion)
Despite the significant role of seasonal influenza vaccination in preventing and minimizing the serious complications of influenza infection in type 2 diabetes mellitus (T2DM) patients, unsatisfactory compliance still exists for vaccination. Study objectives were to explore the vaccination status and determinants in T2DM patients in southwestern Saudi Arabia. A cross-sectional study on a representative sample of T2DM patients in Abha city, southwestern Saudi Arabia, was conducted. Data for sociodemographic characteristics, clinical criteria, vaccination status, vaccination motivators and barriers and seasonal influenza knowledge were collected. Out of 353 T2DM patients included in the study, seasonal influenza vaccination coverage was 61% in year 2017. A significant factors associated with non-vaccination were; poor influenza and its vaccine knowledge (OR = 4.31, 95% CI: 2.73–6.80), illiteracy (OR = 1.93, 95% CI: 1.11–3.37), and more than 10 years disease duration (OR = 2.07, 95% CI: 1.11–3.87). Presence of family history of DM and ischemic heart comorbidity minimized the possibility of non-vaccination (OR = 0.54 and 0.28 respectively). Healthcare givers’ advice was the most reported vaccination motivator (84.7%) while; fear of vaccine side effects was the most stated barrier (73%). In conclusion, influenza vaccination rate among T2DM in the present study is less than the recommended level. Continuous primary health care center-based educational programs should be implemented to aware and encourage influenza vaccination among T2DM patients. View Full-Text
Keywords: diabetes; seasonal influenza vaccination; motivators and barriers; knowledge; determinants diabetes; seasonal influenza vaccination; motivators and barriers; knowledge; determinants
MDPI and ACS Style

Alnaheelah, I.M.; Awadalla, N.J.; Al-Musa, K.M.; Alsabaani, A.A.; Mahfouz, A.A. Influenza Vaccination in Type 2 Diabetes Patients: Coverage Status and Its Determinants in Southwestern Saudi Arabia. Int. J. Environ. Res. Public Health 2018, 15, 1381.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop